Research and Markets: Eczema Therapeutics Market is Forecast to Show Significant Growth until 2018

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/27d1e4/eczema_therapeutic) has announced the addition of GlobalData 's new report "Eczema Therapeutics - Pipeline Assessment and Market Forecasts to 2018" to their offering.

GlobalData, the industry analysis specialist, has released its new report, Eczema Therapeutics - Pipeline Assessment and Market Forecasts to 2018. The report is an essential source of information and analysis on the global Eczema therapeutics market. The report identifies the key trends shaping and driving the global eczema therapeutics market.

The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global eczema therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData estimated the global eczema therapeutics market to value $2,035.5m in 2010. It is expected to grow a Compound Annual Growth Rate (CAGR) of 8.2% to $3,834.5m by 2018. This growth is primarily attributed to an increased prevalence rate and increased patient awareness of the disease pattern. In 2010, the prevalence of eczema reported in seven major geographies (the US, the UK, Germany, France, Spain, Italy and Japan), was between 10-20%.

GlobalData expects that the number of eczema patients will increase, along with an increase in prevalence. Some factors associated with an increased risk of eczema include environmental factors, hygiene conditions, lack of awareness and levels of education. In the pipeline, presence of novel molecules with improved safety, efficacy and tolerability is expected to further drive the market during the forecast period. However, an increase in product competition due to genericization is a barrier for the market which will decrease the growth over the forecast period in comparison to historic growth.

Read more inside Eczema Therapeutics Market is Forecast to Show Significant Growth until 2018

Companies Mentioned:

• Almirall
• Anacor Pharmaceuticals
• BioCis Pharmaceuticals
• MIKA Pharma GmbH
• Novartis AG
• GlaxoSmithKline
• Sanofi

For more information visit http://www.researchandmarkets.com/research/27d1e4/eczema_therapeutic